Clinical Evidence: How Wegovy And Mounjaro Compare In Trials
Wegovy And Mounjaro Weight Loss Results: Understanding The Clinical Evidence
When evaluating Wegovy and Mounjaro weight loss results, clinical trial data provides the most reliable foundation for understanding potential outcomes. Wegovy's efficacy has been demonstrated through the comprehensive STEP trial programme, whilst Mounjaro's results come from the SURMOUNT studies. Both prescription-only medicines work through different mechanisms - Wegovy as a GLP-1 receptor agonist and Mounjaro as a dual GIP/GLP-1 receptor agonist - creating distinct therapeutic profiles.
The clinical evidence for both Wegovy and Mounjaro shows substantial weight management potential when used alongside a reduced-calorie diet and increased physical activity. However, comparing trial results directly requires careful consideration of different study designs, patient populations, and endpoints. Understanding these nuances helps patients and prescribers make informed decisions about which treatment may be most appropriate for individual circumstances.
Wegovy And Mounjaro Pricing: UK Treatment Costs And Value Comparison
Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99) to the maintenance 2.4mg dose (£209.99). Our bundle options provide convenient supply management, with the Intro Duo (0.25mg & 0.5mg) available for £169.99 and the Progress Trio (0.5mg, 1mg & 1.7mg) priced at £369.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25.
When comparing Wegovy and Mounjaro costs, both treatments require ongoing investment in your health journey. The dose escalation schedule for Wegovy follows a structured 16-week titration period before reaching maintenance dosing, allowing your body to gradually adapt whilst minimising potential side effects. EverydayMeds provides transparent pricing without hidden fees, ensuring you understand your treatment investment from the start of your weight management journey.
Wegovy And Mounjaro Clinical Trial Results: STEP And SURMOUNT Data
The STEP clinical trial programme demonstrates Wegovy's efficacy across multiple studies. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 combined Wegovy with intensive behavioural therapy, showing approximately 16% weight reduction.
Long-term sustainability data from STEP 5 revealed approximately clinically studied weight loss maintained at two years, whilst the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These results position Wegovy and Mounjaro as evidence-based options for weight management, though individual responses may vary significantly from clinical trial averages.
How Wegovy Works: GLP-1 Mechanism In Wegovy And Mounjaro Comparison
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates blood sugar and appetite. When you inject Wegovy weekly, it activates GLP-1 receptors in your brain's appetite control centres, promoting feelings of satiety and reducing food cravings. This mechanism slows gastric emptying, helping you feel fuller for longer periods after meals. Mounjaro works differently as a dual agonist, targeting both GIP and GLP-1 receptors simultaneously. Understanding these mechanistic differences between Wegovy and Mounjaro helps explain why individual responses may vary, making prescriber guidance essential for optimal treatment selection.
Ordering Wegovy And Mounjaro: EverydayMeds Assessment Process
Accessing Wegovy and Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for weight management treatment. Our qualified prescribers review your medical history, current medications, and weight management goals within 3 working days (or 24 hours with express service). Once approved, your prescription-only medicine is dispatched via next-day delivery using temperature-controlled, cold-chain logistics to maintain medication integrity. This streamlined process ensures you receive genuine Wegovy or Mounjaro without compromising on clinical safety standards. Our GPhC-registered pharmacy (#9012878) maintains strict protocols for prescription verification and medication handling throughout the entire process.
Wegovy And Mounjaro Storage: Practical Considerations For UK Patients
Proper storage of Wegovy and Mounjaro ensures medication effectiveness and safety throughout your treatment. Both require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks of room temperature storage below 30°C compared to Mounjaro's 21-day limit. The Wegovy FlexTouch pen delivers precise dosing through its user-friendly design, progressing from 0.25mg starter doses to 2.4mg maintenance levels over 16 weeks. This structured dose escalation helps minimise side effects whilst optimising therapeutic benefits. Always store your unused pens in the original carton to protect from light, and never freeze or use medication that has been frozen, as this can compromise the active ingredient's stability.
UK-Specific Wegovy And Mounjaro Results: NICE Guidelines And NHS Context
Within the UK healthcare system, both Wegovy and Mounjaro are recognised through NICE technology appraisals, with Wegovy receiving recommendation TA875 for specialist weight management support. UK-specific data shows particular relevance for patients with BMI ≥30 or BMI ≥27 with weight-related comorbidities, aligning with MHRA licensing conditions. The NHS perspective on Wegovy and Mounjaro emphasises their role within comprehensive lifestyle intervention programmes rather than standalone treatments.
For UK patients accessing Wegovy and Mounjaro privately through EverydayMeds, understanding this clinical context ensures realistic expectations about treatment outcomes. Our prescribers apply the same rigorous assessment criteria used in NHS settings, ensuring appropriate patient selection whilst providing convenient private access to these transformative weight management medications.
Accessing Wegovy And Mounjaro: Complete Your Assessment Today
Both Wegovy and Mounjaro are available from EverydayMeds following successful completion of our clinical assessment process. Start your weight management journey by selecting the appropriate treatment option and using discount code FIRST40 for new customers or DOSE25 for returning patients. Our qualified prescribers will review your application and guide you towards the most suitable option based on your individual medical profile. The combination of clinical expertise, competitive pricing, and reliable delivery makes EverydayMeds your trusted partner for accessing these prescription-only medicines safely and conveniently. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take the first step towards evidence-based weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
